Related Experiment Video

Updated: Aug 8, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

808

Krüppel-Like Factor 2 Is a Gastric Cancer Suppressor and Prognostic Biomarker

Xi-Mei Li1,2, Sheng-Juan Hu2, Jian-Fang Liu2

  • 1School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia 750004, China.

Evidence-Based Complementary and Alternative Medicine : Ecam
|March 6, 2023
PubMed

Insights

Kruppel-like factor 2 (KLF2) is downregulated in gastric cancer (GC), correlating with poor prognosis. Low KLF2 promotes GC cell growth and invasion, suggesting it is a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric cancer (GC) presents complex pathogenesis with unsatisfactory diagnostic and therapeutic outcomes.
  • Kruppel-like factor 2 (KLF2) is a known tumor suppressor implicated in various cancers, but its specific role in GC remains largely unelucidated.

Purpose of the Study:

  • To investigate the expression levels, prognostic significance, and functional role of KLF2 in gastric cancer.

Main Methods:

  • Bioinformatic analysis and RT-qPCR were used to assess KLF2 mRNA levels.
  • Immunohistochemistry on tissue microarrays evaluated KLF2 protein expression.
  • Functional experiments involved knockdown of KLF2 in GC cell lines (HGC-27 and AGS).

Main Results:

  • KLF2 mRNA and protein expression were significantly downregulated in GC tissues compared to normal adjacent tissues.
  • Reduced KLF2 expression correlated with advanced T stage, older patient age, and poorer overall survival.
  • KLF2 knockdown enhanced the proliferation, migration, and invasion capabilities of GC cells.

Conclusions:

  • Downregulation of KLF2 is associated with aggressive biological behavior and poor prognosis in gastric cancer.
  • KLF2 functions as a tumor suppressor in GC.
  • KLF2 represents a potential prognostic biomarker and therapeutic target for gastric cancer.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K
Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

500

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K